Nurulimab (Anti-CTLA-4 / CD152)
Product Specifications
CAS Number
2168561-20-2
SKU
C00615-1mg
Target
Immunology & Inflammation related
Applications
Immunology & Inflammation
Additionnal Information
Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![(E)-3-(2-Fluorophenyl)-N-((S)-1-(3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]acrylamide](https://cdn.genprice.uk/products/572/4721503763738/imageurl/trc-f595708-5mg.webp)
TRC-F595708-5MG 5 mg
(E)-3-(2-Fluorophenyl)-N-((S)-1-(3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]acrylamide
Sign In for Pricing
View Details 